Remote Consultation Systems in Florida

Healthcare MIT Services (HMS) is a medical technology company delivering AI-powered diagnostic imaging, intelligent patient monitoring, and connected care solutions. The company manufactures and distributes portable imaging systems, including low-dose fluoro-radiography and tabletop X-ray equipment designed for point-of-care, remote, and field deployment. Key product lines include contactless fall management and bedside monitoring systems utilizing AI-driven analysis without cameras or wearables; AI-enabled respiratory monitoring with noise-filtering capabilities; and clinical chemistry analyzers capable of running 16 tests in under 5 minutes with minimal blood samples (<90μL), ideal for remote and point-of-care settings. HMS also offers intelligent healthcare software solutions spanning smart ward and mobile nursing platforms, telehealth and remote care systems, and smart operating room integration. Medical supplies include certified PPE, mobile carts, and ready-to-deploy clinical kits. The company holds certifications including ISO 9001, ISO 13485, FDA clearance, EN 60601-1 medical device standard compliance, GMP, FCC, CUL, and CSA. HMS markets to hospitals, clinics, long-term care facilities, and field medical teams globally, with demonstrated presence at major medical conferences (HIMSS, RSNA, DMEA, AHCA/NCAL). The company emphasizes AI integration, radiation reduction, mobility, and safety across its product portfolio.

Aventusoft, LLC is a Boca Raton, Florida-based medical technology company specializing in signal detection analysis and AI-driven digital health platforms since 2010. The company develops innovative solutions focused on cardiac monitoring, clinical decision support, and decentralized clinical research. Primary product lines include Hemotag, a non-invasive cardiac monitoring device paired with AI analytics to reduce reliance on invasive cardiac imaging and implantable devices; CarePear, a digital health platform connecting patients and physicians with US-based sub-specialists through AI-enabled telemedicine; and Trialogy, an AI-driven platform for decentralized clinical trials that streamlines life science research. Aventusoft has received recognition from the NIH (RADx Tech for Maternal Health Challenge), DARPA, American College of Cardiology (ACC Innovation Showcase Award 2021 and 2023), and multiple design and innovation awards. The company demonstrated 146% two-year revenue growth and ranked No. 112 on Inc. Magazine's 2023 Southeast Region fastest-growing private companies list. Products target cardiac care, maternal health, specialist access, and clinical research domains, with regulatory focus on maternal health applications and AI-driven diagnostics.

Heru, Inc. is an ophthalmology and eye care technology company founded on clinical research from the University of Miami's Bascom Palmer Eye Institute, the nation's leading eye hospital. The company develops wearable headset-based vision testing systems and digital eye care platforms, with a primary focus on visual field testing, glaucoma screening, and tele-optometry solutions. Heru's flagship product, Heru Prime, is a next-generation multimodal platform designed to standardize patient pretesting and elevate clinical workflows. The company also offers EyeStream™ technology, a pretesting solution that reduces manual variability in patient assessment. Heru's systems are designed for optometry practices, ophthalmology clinics, and telehealth platforms seeking to improve patient throughput and diagnostic accuracy. The company has received recognition as a CES 2023 Innovation Awards Honoree in the Virtual and Augmented Reality category for two consecutive years, validating the clinical efficacy and innovation of its wearable headset approach. Heru conducts clinical validation studies comparing its wearable-based visual field measurements against standard automated perimetry, demonstrating comparable accuracy in a more accessible format. The platform supports tele-optometry strategies, allowing remote eye care delivery with standardized pretesting protocols.

Solaborate Inc. develops hellocare, an integrated end-to-end telehealth and virtual healthcare delivery platform combining software, hardware, and artificial intelligence. The platform serves hospitals, home care, and primary care settings, enabling clinicians to deliver remote patient care through multiple modalities: virtual patient observation (up to 16 rooms monitored simultaneously), telehealth consultations, remote patient monitoring (RPM), and digital clinic services. Core capabilities include real-time audio/video communication, secure messaging, EHR integration, dynamic workflow management, and AI-driven alerting for fall detection and patient behavior monitoring. The company supplies integrated telemedicine carts (mobile hardware and software solutions), remote examination kits that enable physicians to assess vital signs and conduct clinical examinations from patient homes, and communication tools linking clinicians, nurses, and healthcare teams. The platform processes continuous patient observation data, captures health metrics from connected medical devices, and uses edge-based AI algorithms to generate clinical alerts while maintaining patient privacy. Solaborate maintains HIPAA compliance, HITRUST certification, SOC 2 attestation (AICPA), and CE marking. The platform is used by major healthcare systems including Amwell, Northwell Health, and Swiss healthcare organizations. Intended for B2B deployment in hospital systems, urgent care, home health agencies, and telemedicine networks requiring turnkey virtual care delivery infrastructure.